Comprehensive Psychosis Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034

Which drivers are expected to have the greatest impact on the over the psychosis market's growth?
The increasing cases of mental health conditions are expected to propel the growth of the psychosis market. Mental health conditions, including psychosis, are becoming more prevalent, particularly due to rising stress levels, lifestyle changes, and social isolation. These conditions are often treated with antipsychotic medications and therapy options. According to the National Alliance on Mental Illness, psychosis and mood disorders account for nearly 600,000 hospitalizations annually among individuals aged 18-44 in the U.S. The rising number of mental health conditions, along with growing awareness and treatment options, is driving the growth of the psychosis market as more people seek medical intervention.

Get Your Psychosis Market Report Here:
https://www.thebusinessresearchcompany.com/report/psychosis-global-market-report

What is the future CAGR of the psychosis market, and how will it impact industry expansion?
The psychosis market has grown steadily, increasing from $9.88 billion in 2024 to $10.49 billion in 2025 at a CAGR of 6.1%. Growth drivers include rising cases of mental health conditions, increasing demand for mental health therapeutics, wider adoption of typical and atypical antipsychotics, greater use of cognitive behavioral therapy (CBT), and the impact of stress-inducing global and economic factors.

The psychosis market is expected to experience robust growth, reaching $13.13 billion by 2029 at a CAGR of 5.8%. Factors fueling this growth include the increasing prevalence of stress-related conditions, rising mental health concerns due to lifestyle changes, government initiatives, greater adoption of mindfulness-based therapies, and increased investments in mental health research. Notable trends include the introduction of innovative drug therapies, advancements in diagnostic tools, the development of injectable treatments, the use of biomarkers, and a growing demand for personalized medications.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21266&type=smp

What are the most significant trends transforming the psychosis market today?
Leading companies in the psychosis market are focusing on the development of advanced virtual reality (VR) psychological therapy to enhance treatment outcomes through interactive and personalized mental health interventions. VR psychological therapy immerses individuals in controlled, computer-generated environments to reduce distress, enhance cognitive function, and improve social skills through guided interventions, offering a safe and effective approach to symptom management. For example, in April 2022, OxfordVR, a US-based digital therapeutics company, introduced gameChangeVR to guide patients through cognitive behavioral therapy (CBT) in immersive virtual scenarios. The automated VR therapy, delivered across six weekly sessions, demonstrated significant benefits, especially for those facing severe psychological challenges, improving their paranoia and overall quality of life. This technology has the potential to greatly expand access to effective mental health care, addressing the shortage of clinicians and providing a scalable solution for treating millions of patients with severe mental illness.

Which key market segments comprise the psychosis market and drive its revenue growth?
The psychosis market covered in this report is segmented -

1) By Product: Tablet, Capsule, Injection
2) By Disease Type: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Disease Types
3) By Distribution Channel: Online, Offline
4) By End-User: Hospitals, Healthcare Clinics, Speciality Clinics, Other End-Users

Subsegments:
1) By Tablet: Antipsychotic Tablets, Mood Stabilizer Tablets
2) By Capsule: Antipsychotic Capsules, Antidepressant Capsules
3) By Injection: Long-acting Injectable Antipsychotics, Short-acting Injectable Antipsychotics

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21266

What regions are at the forefront of psychosis market expansion?
North America was the largest region in the psychosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the psychosis market?
Major companies operating in the psychosis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Biogen Idec, Dr. Reddy's Laboratories Ltd., Lundbeck A/S, Gedeon Richter, Alkermes, Supernus Pharmaceuticals, Acadia Pharmaceuticals, Neuron Pharmaceuticals, Mapi Pharma, Astellas Pharma Inc., Newron Pharmaceuticals S.p.A., Anavex Life Sciences, BioXcel Therapeutics

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21266&type=smp

What Is Covered In The Psychosis Global Market Report?

•Market Size Forecast: Examine the psychosis market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the psychosis market for a structured understanding.
•Key Players Overview: Analyze major players in the psychosis market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the psychosis market.
•Segment Contributions: Evaluate how different segments drive overall growth in the psychosis market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the psychosis market.
•Industry Challenges: Identify potential risks and obstacles affecting the psychosis market.
•Competitive Landscape: Review strategic developments in the psychosis market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.